RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
מצבים רפואיים
Adenocarcinoma of Lung · Lung Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Dr. Amit Kulkarni, Phoenix, Arizona, United States
MNCCTN Essentia Health St. Joseph's Brainerd Medical Center, Brainerd, Minnesota, United States
MNCCTN Essentia Health Deer River, Deer River, Minnesota, United States
MNCCTN Essentia Health St. Mary's Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States
MNCCTN Essentia Health Duluth, Duluth, Minnesota, United States
MNCCTN Essentia Health Fosston, Fosston, Minnesota, United States
MNCCTN Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
MNCCTN Essentia Health Sandstone, Sandstone, Minnesota, United States
MNCCTN Essentia Health Virginia Clinic, Virginia, Minnesota, United States
מובילי המחקר
Manish Patel, DO
Principal Investigator
University of Minnesota, Division of Hematology, Oncology and Transplantation